Pure Bioscience Inc was incorporated in the state of California on August 24, 1992. It has initial public offering in August 1996. The Company is engaged in the discovery, development and commercialization of bioscience products that provide solutions to health challenges. Its technology platform is based on stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial. The Company manufactures and sells SDC-based disinfecting and sanitizing products, which are registered by the Environmental Protection Agency, or EPA, to distributors and end users. It also manufactures and sells various SDC-based formulations to manufacturers for use as a raw material in the production of personal care and other products. The foundation of its technology platform is a proprietary electrochemical process that allows it to generate ionized silver in the presence of organic acid. This process creates a solution containing stabilized ionic silver that can function as an antimicrobial. Its current products contain SDC, which is produced by ionizing silver in citric acid. SDC is non-toxic, non-caustic, colorless, odourless and formulates well with other compounds. The Company believes that SDC is distinguished from other products in the marketplace because of its superior efficacy and toxicity profiles. The Company manufactures and packages its disinfectant and sanitizing products as well as various raw material formulations at its corporate headquarters in El Cajon, California. The Company's business is subject to various government regulations relating to the protection of public health and the environment.